1: Komatsu Y, Nakamura A, Takihata M, Inoue Y, Yahagi S, Tajima K, Tsuchiya H, Takano T, Yamakawa T, Yoshida M, Miyoshi H, Terauchi Y. Safety and tolerability of diazoxide in Japanese patients with hyperinsulinemic hypoglycemia. Endocr J. 2015 Nov 20. [Epub ahead of print] PubMed PMID: 26598136.
2: Chen W, Liu Y, Xue G, Zhang L, Zhang L, Shao S. Diazoxide protects L6 skeletal myoblasts from H2O2-induced apoptosis via the phosphatidylinositol-3 kinase/Akt pathway. Inflamm Res. 2016 Jan;65(1):53-60. doi: 10.1007/s00011-015-0890-1. Epub 2015 Nov 2. PubMed PMID: 26525360.
3: Zhu J, Fu Q, Xia C, Ma G. Effects of diazoxide on Aβ1-42-induced expression of the NR2B subunit in cultured cholinergic neurons. Mol Med Rep. 2015 Dec;12(6):8301-5. doi: 10.3892/mmr.2015.4457. Epub 2015 Oct 21. PubMed PMID: 26496862.
4: Villoslada P, Rovira A, Montalban X, Arroyo R, Paul F, Meca-Lallana V, Ramo C, Fernandez O, Saiz A, Garcia-Merino A, Ramió-Torrentà L, Casanova B, Oreja-Guevara C, Muñoz D, Martinez-Rodriguez JE, Lensch E, Prieto JM, Meuth SG, Nuñez X, Campás C, Pugliese M; NeuroAdvan study. Effects of diazoxide in multiple sclerosis: A randomized, double-blind phase 2 clinical trial. Neurol Neuroimmunol Neuroinflamm. 2015 Sep 10;2(5):e147. doi: 10.1212/NXI.0000000000000147. eCollection 2015 Oct. PubMed PMID: 26405686; PubMed Central PMCID: PMC4567455.
5: Newfield RS. Topical sulfonylurea as a novel therapy for hypertrichosis secondary to diazoxide, and potentially for other conditions with excess hair growth. Med Hypotheses. 2015 Dec;85(6):969-71. doi: 10.1016/j.mehy.2015.08.025. Epub 2015 Sep 5. PubMed PMID: 26392140.
6: Shah P, Rahman SA, McElroy S, Gilbert C, Morgan K, Hinchey L, Senniappan S, Levy H, Amin R, Hussain K. Use of Long-Acting Somatostatin Analogue (Lanreotide) in an Adolescent with Diazoxide-Responsive Congenital Hyperinsulinism and Its Psychological Impact. Horm Res Paediatr. 2015;84(5):355-60. doi: 10.1159/000439131. Epub 2015 Sep 17. PubMed PMID: 26375451.
7: Ali M, Mehmood A, Anjum MS, Tarrar MN, Khan SN, Riazuddin S. Diazoxide preconditioning of endothelial progenitor cells from streptozotocin-induced type 1 diabetic rats improves their ability to repair diabetic cardiomyopathy. Mol Cell Biochem. 2015 Dec;410(1-2):267-79. doi: 10.1007/s11010-015-2560-6. Epub 2015 Sep 10. PubMed PMID: 26359087.
8: Nelson BW, Van Wagoner DR. How Does Diazoxide Elicit Arrhythmias in Rats With Type 2 Diabetes?: Is This Effect Clinically Significant? J Am Coll Cardiol. 2015 Sep 8;66(10):1157-9. doi: 10.1016/j.jacc.2015.07.028. PubMed PMID: 26337995.
9: Xie C, Hu J, Motloch LJ, Karam BS, Akar FG. The Classically Cardioprotective Agent Diazoxide Elicits Arrhythmias in Type 2 Diabetes Mellitus. J Am Coll Cardiol. 2015 Sep 8;66(10):1144-56. doi: 10.1016/j.jacc.2015.06.1329. PubMed PMID: 26337994; PubMed Central PMCID: PMC4560843.
10: Henn MC, Janjua MB, Kanter EM, Makepeace CM, Schuessler RB, Nichols CG, Lawton JS. Adenosine Triphosphate-Sensitive Potassium Channel Kir Subunits Implicated in Cardioprotection by Diazoxide. J Am Heart Assoc. 2015 Aug 24;4(8):e002016. doi: 10.1161/JAHA.115.002016. PubMed PMID: 26304939; PubMed Central PMCID: PMC4599460.